Towards the National Platform for Genomic Surveillance

Grant number: 101113409

Grant search

Key facts

  • Disease

    COVID-19, Unspecified
  • Start & end year

    2022
    2025
  • Known Financial Commitments (USD)

    $1,928,999.23
  • Funder

    European Commission
  • Principal Investigator

    Gierczyński Rafał
  • Research Location

    Poland
  • Lead Research Institution

    NARODOWY INSTYTUT ZDROWIA PUBLICZNEGO PZH - PANSTWOWY INSTYTUT BADAWCZY
  • Research Priority Alignment

    N/A
  • Research Category

    Epidemiological studies

  • Research Subcategory

    Disease surveillance & mapping

  • Special Interest Tags

    Data Management and Data SharingInnovation

  • Study Type

    Not applicable

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

The PLEpiSeq project is a continuation of the previous project - HERA I, which aimed at creating the bioinformatic platform for genomic-based national epidemiological surveillance in Poland. The platform provides (I) the infrastructure for genomic data storage and computations, (II) tools to support integrations of SARS-CoV-2 genomic sequence data with relevant metadata, (III) algorithms for improving the sequencing representation (algorithms generating random samples), and (IV) pipeline for standardized analysis of raw SARS-CoV-2 sequencing data obtained from laboratories in Poland. With this proposal, we aim to address the molecular epidemiology of other pathogens (i.e. Influenza virus and Salmonella). This will enhance epidemiological surveillance for these diseases in Poland, improve our understanding of how they evolve and spread, allowing for implementation of adequate disease control measures. Successful completion of the project will result in improved links between genomic data and contextual metadata and standardization of laboratory protocols, increase in capacity for advanced bioinformatic analysis and visualization of their results, as well as in building workforce capacity and networking in genomic surveillance. Overall, it will enhance our capacity for outbreak investigation, routine surveillance and responding to future health crises.